These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6068312)

  • 1. Irreversible enzyme inhibitors. XCV. 8-(m-bromoacetamidobenzylthio)hypoxanthine, an active-site-directed irreversible inhibitor of xanthine oxidase.
    Baker BR; Kozma J
    J Med Chem; 1967 Jul; 10(4):682-5. PubMed ID: 6068312
    [No Abstract]   [Full Text] [Related]  

  • 2. A kinetic study of hypoxanthine oxidation by milk xanthine oxidase.
    Escribano J; Garcia-Canovas F; Garcia-Carmona F
    Biochem J; 1988 Sep; 254(3):829-33. PubMed ID: 3196295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase (XO): relative configuration of complexes formed by the enzyme, 2- or 8-n-alkyl-hypoxanthines and 2-n-alkyl-8-azahypoxanthines. XII.
    Biagi G; Giorgi I; Livi O; Scartoni V; Tonetti I; Lucacchini A
    Farmaco; 1993 Mar; 48(3):357-74. PubMed ID: 8323669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate inhibition of xanthine oxidase and its influence on superoxide radical production.
    Rubbo H; Radi R; Prodanov E
    Biochim Biophys Acta; 1991 Aug; 1074(3):386-91. PubMed ID: 1653611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.
    Baker BR; Shapiro HS
    J Pharm Sci; 1967 Jan; 56(1):33-8. PubMed ID: 6030490
    [No Abstract]   [Full Text] [Related]  

  • 6. Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I.
    Baker BR; Jackson GD; Meyer RB
    J Pharm Sci; 1967 May; 56(5):566-70. PubMed ID: 6040577
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3.
    Baker BR; Meyer RB
    J Pharm Sci; 1967 May; 56(5):570-6. PubMed ID: 6032766
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxylation of phenylalanine by the hypoxanthine-xanthine oxidase system.
    Ishimitsu S; Fujimoto S; Ohara A
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4645-9. PubMed ID: 6549439
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. LXX. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IV. Substituted 1-phenyl-1,2-dihydro-s-triazines.
    Baker BR; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):28-32. PubMed ID: 6030489
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. LXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VI. Derivatives of hydrophobically bonded p-alkyl and p-aralkyl benzoic acids.
    Baker BR; Schwan TJ; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):38-42. PubMed ID: 6030491
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme inhibitors. XV. A new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Odin E
    J Med Chem; 1967 Mar; 10(2):181-3. PubMed ID: 6068034
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylated 7-deazahypoxanthines as regiochemical probes of xanthine oxidase.
    Rosemeyer H; Seela F
    Eur J Biochem; 1983 Aug; 134(3):513-5. PubMed ID: 6688395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical localization and possible antibacterial role of xanthine oxidase in the bovine mammary gland.
    Collins RA; Parsons KR; Field TR; Bramley AJ
    J Dairy Res; 1988 Feb; 55(1):25-32. PubMed ID: 3385064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower xanthine oxidoreductase activity in isolated perfused hearts if xanthine replaces hypoxanthine as substrate.
    Janssen M; de Jong JW; Nieukoop AS; Keijzer E
    Adv Exp Med Biol; 1991; 309A():357-60. PubMed ID: 1789243
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidation of hypoxanthines, bearing 8-aryl or 8-pyridyl substituents, by bovine milk xanthine oxidase.
    Bergmann F; Levene L; Govrin H
    Biochim Biophys Acta; 1977 Oct; 484(2):275-89. PubMed ID: 20959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of xanthine oxidase with the bovine milk-fat-globule membrane.
    Briley MS; Eisenthal R
    Biochem J; 1974 Oct; 143(1):149-57. PubMed ID: 4156954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine accumulation during hypoxanthine oxidation by milk xanthine oxidase.
    Jezewska MM
    Eur J Biochem; 1973 Jul; 36(2):385-90. PubMed ID: 4740970
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of uric acid biosynthesis in the chick embryo and chicken by a xanthine oxidase inhibitor, 4-hydroxypyrazolo(3,4d)pyrimidine.
    Krakoff IH; Meyer RL
    J Pharmacol Exp Ther; 1965 Sep; 149(3):417-22. PubMed ID: 5848052
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of 8-substitutes on the oxidation of hypoxanthine and 6-thioxopurine by bovine milk xanthine oxidase.
    Bergmann F; Levene L; Govrin H; Frank A
    Biochim Biophys Acta; 1977 Jan; 480(1):39-46. PubMed ID: 12828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous assay of hypoxanthine, xanthine and allopurinol by high-performance liquid chromatography and activation of immobilized xanthine oxidase as an enzyme reactor.
    Kito M; Tawa R; Takeshima S; Hirose S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2459-62. PubMed ID: 2605692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.